Cargando…
Effect of Intravitreal Methotrexate and Rituximab on Interleukin-10 Levels in Aqueous Humor of Treated Eyes with Vitreoretinal Lymphoma
Intraocular cytokines are promising diagnostic biomarkers of vitreoretinal lymphoma. Here, we evaluate the utility of IL-10, IL-6 and IL-10/IL-6 for discriminating lymphoma from uveitis and report the effects of intraocular methotrexate and rituximab on aqueous cytokine levels in eyes with lymphoma....
Autores principales: | Raja, Harish, Snyder, Melissa R., Johnston, Patrick B., O’Neill, Brian P., Caraballo, Juline N., Balsanek, Joseph G., Peters, Brian E., Decker, Paul A., Pulido, Jose S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672178/ https://www.ncbi.nlm.nih.gov/pubmed/23750271 http://dx.doi.org/10.1371/journal.pone.0065627 |
Ejemplares similares
-
Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma
por: Anthony, Casey L., et al.
Publicado: (2021) -
Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate
por: Jiang, Tingting, et al.
Publicado: (2022) -
Serial changes in the aqueous IL-10 level after intravitreal methotrexate injection as an indicator of primary vitreoretinal lymphoma recurrence
por: Park, Young Gun, et al.
Publicado: (2020) -
Lenalidomide and Rituximab Regimen Combined With Intravitreal Methotrexate Followed by Lenalidomide Maintenance for Primary Vitreoretinal Lymphoma: A Prospective Phase II Study
por: Zhang, Yan, et al.
Publicado: (2021) -
Long‐term outcomes of combined intravitreal methotrexate and systemic high‐dose methotrexate therapy in vitreoretinal lymphoma
por: Cheng, Chieh‐Lung, et al.
Publicado: (2023)